Escolar G, Arellano-Rodrigo E, Lopez-Vilchez I, Molina P, Sanchis J, Reverter JC, Carne X, Cid J, Villalta J, Tàssies D, Galán AM, Diaz-Ricart M
Circ. J.. 2015;79(2):331-8, PMID: 25482382
Despite the good safety of rivaroxaban, there is limited information on strategies for urgent reversal of its antihemostatic effects.
CARDIAC & CARDIOVASCULAR SYSTEMS